Infusystem Holdings Inc Quick Ratio (INFU) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Infusystem Holdings Inc  (NYSEAMER: INFU)

Infusystem Holdings Inc's Quick Ratio

INFU's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.06 below Infusystem Holdings Inc's average Quick Ratio.

Within Medical Equipment & Supplies industry 184 other companies have achieved higher Quick Ratio than Infusystem Holdings Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3143 to 3878.

Explain Quick Ratio?
How much Cash & cash equivalents INFU´s has?
What are INFU´s Current Liabilities?




INFU Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -3.54 % 7.35 % 14.27 % 10.52 % -0.12 %
Y / Y Cash & cash equivalent Change 33.89 % 39.84 % 504.55 % 151.32 % 393.15 %
Quick Ratio MRQ 0.06 0.12 0.16 0.05 0.05
INFU's Total Ranking # 3878 # 3143 # 2070 # 2814 # 3390
Seq. Current Liabilities Change -10.75 % -15.06 % 7.82 % 18.01 % -0.68 %
Seq. Cash & cash equivalent Change -54.23 % -33.9 % 233.61 % 32.64 % -52.19 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 185
Healthcare Sector # 856
Overall Market # 3878


Quick Ratio Statistics
High Average Low
0.63 0.1 0
(Dec 31 2010)   (Mar 31 2017)




Financial Statements
Infusystem Holdings Inc's Current Liabilities $ 15 Millions Visit INFU's Balance sheet
Infusystem Holdings Inc's Cash & cash equivalent $ 1 Millions Visit INFU's Balance sheet
Source of INFU's Sales Visit INFU's Sales by Geography


Cumulative Infusystem Holdings Inc's Quick Ratio

INFU's Quick Ratio for the trailling 12 Months

INFU Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 7.4 % 8.21 % 4.34 % 3.6 % 5.14 %
Y / Y Cash & cash equivalent TTM Growth 130.16 % 172.25 % 239.57 % 134.83 % 130.37 %
Quick Ratio TTM 0.1 0.1 0.09 0.05 0.05
Total Ranking TTM # 4138 # 3019 # 3172 # 3098 # 3170
Seq. Current Liabilities TTM Growth -0.78 % 1.66 % 3.7 % 2.68 % -0.03 %
Seq. Cash & cash equivalent TTM Growth 3.5 % 9.42 % 71.71 % 18.35 % 22.43 %


On the trailing twelve months basis In spite of the year on year decrease in INFU's Current Liabilities to $15.30 millions, cumulative Quick Ratio to 0.1 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Infusystem Holdings Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3019 to 4138.

Explain Quick Ratio?
How much Cash & cash equivalents INFU´s has?
What are INFU´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 914
Within the Market # 4138


trailing twelve months Quick Ratio Statistics
High Average Low
0.23 0.09 0.01
(Dec 31 2018)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Catheter Precision Inc   0.16 $ 1.839  Millions$ 11.166  Millions
Zimmer Biomet Holdings Inc   0.14 $ 410.000  Millions$ 3,013.500  Millions
Nexgel Inc   0.12 $ 1.692  Millions$ 14.440  Millions
Ufp Technologies Inc   0.12 $ 9.045  Millions$ 78.304  Millions
Solventum Corporation  0.11 $ 403.000  Millions$ 3,663.000  Millions
Nakamoto Inc   0.11 $ 19.072  Millions$ 179.474  Millions
Petvivo Holdings Inc   0.10 $ 0.135  Millions$ 1.313  Millions
The Pennant Group Inc   0.10 $ 15.273  Millions$ 152.406  Millions
Non Invasive Monitoring Systems Inc  0.10 $ 0.160  Millions$ 1.607  Millions
Boston Scientific Corporation  0.10 $ 749.000  Millions$ 7,530.000  Millions
Integer Holdings Corporation  0.10 $ 21.375  Millions$ 217.141  Millions
Bellevue Life Sciences Acquisition Corp  0.10 $ 1.500  Millions$ 15.734  Millions
National Vision Holdings Inc   0.09 $ 35.998  Millions$ 383.026  Millions
Becton Dickinson And Company  0.09 $ 864.000  Millions$ 9,404.000  Millions
Vivos Therapeutics Inc   0.09 $ 1.774  Millions$ 20.389  Millions
The Cooper Companies Inc   0.08 $ 154.900  Millions$ 1,866.600  Millions
Infusystem Holdings Inc  0.06 $ 0.964  Millions$ 15.300  Millions
Vsee Health Inc   0.06 $ 0.454  Millions$ 8.139  Millions
P3 Health Partners Inc   0.05 $ 21.272  Millions$ 388.581  Millions
Henry Schein Inc   0.05 $ 157.000  Millions$ 3,488.000  Millions
Yunhong Green Cti Ltd   0.04 $ 0.320  Millions$ 8.371  Millions
3m Company  0.03 $ 387.000  Millions$ 11,379.000  Millions
Vycor Medical Inc   0.03 $ 0.165  Millions$ 4.930  Millions
Dror Ortho-Design, Inc.  0.02 $ 0.085  Millions$ 4.100  Millions
Nu med Plus Inc   0.02 $ 0.005  Millions$ 0.280  Millions
Enovis Corp  0.02 $ 12.563  Millions$ 735.625  Millions
Agape Atp Corporation  0.02 $ 0.045  Millions$ 2.939  Millions

Date modified: 2026-09-26T06:50:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.